{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:02:05Z","timestamp":1781071325879,"version":"3.54.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16815678"],"award-info":[{"award-number":["16815678"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/ijnp\/pyx089","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T07:07:23Z","timestamp":1506928043000},"page":"207-215","source":"Crossref","is-referenced-by-count":62,"title":["Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study"],"prefix":"10.1093","volume":"21","author":[{"given":"Yuki","family":"Kageyama","sequence":"first","affiliation":[{"name":"Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Saitama, Japan"},{"name":"Department of Neuropsychiatry, Osaka City University, Graduate School of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaoki","family":"Kasahara","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takemichi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Molecular Structure Characterization Unit, RIKEN Center for Sustainable Resource Science, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Hattori","sequence":"additional","affiliation":[{"name":"Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Deguchi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Osaka City University, Graduate School of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehide","family":"Tani","sequence":"additional","affiliation":[{"name":"Tani Mental Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Hannan Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan"},{"name":"Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ichi","family":"Goto","sequence":"additional","affiliation":[{"name":"Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Osaka City University, Graduate School of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi","family":"Kato","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"key\n\t\t\t\t20180305091448_CIT0001","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn2059","article-title":"Lipid raft microdomains and neurotransmitter signalling","volume":"8","author":"Allen","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"key\n\t\t\t\t20180305091448_CIT0002","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jad.2015.04.024","article-title":"Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: a naturalistic study","volume":"182","author":"Altamura","year":"2015","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t20180305091448_CIT0003","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"key\n\t\t\t\t20180305091448_CIT0004","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/mp.2011.167","article-title":"Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals","volume":"17","author":"Amminger","year":"2012","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0005","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1038\/ncomms8934","article-title":"Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study","volume":"6","author":"Amminger","year":"2015","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t20180305091448_CIT0006","doi-asserted-by":"crossref","first-page":"e10635","DOI":"10.1371\/journal.pone.0010635","article-title":"Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study","volume":"5","author":"Assies","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180305091448_CIT0007","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/pcn.12386","article-title":"Biological aspects and candidate biomarkers for psychotic bipolar disorder: a systematic review","volume":"70","author":"Buoli","year":"2016","journal-title":"Psychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20180305091448_CIT0008","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1021\/pr300459d","article-title":"Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperdone","volume":"11","author":"Cai","year":"2012","journal-title":"J Proteome Res"},{"key":"key\n\t\t\t\t20180305091448_CIT0009","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tifs.2009.07.002","article-title":"Metabolomic analysis in food science: a review","volume":"20","author":"Cevallos-Cevallos","year":"2009","journal-title":"Trends Food Sci Technol"},{"key":"key\n\t\t\t\t20180305091448_CIT0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0924-977X(02)00130-X","article-title":"Polyunsaturated fatty acid deficit in patients with bipolar mania","volume":"13","author":"Chiu","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180305091448_CIT0011","article-title":"Nervonic acid derivatives, their preparation and use","author":"Coupland","year":"2003","journal-title":"U.S. Patent"},{"key":"key\n\t\t\t\t20180305091448_CIT0012","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1073\/pnas.1114410109","article-title":"The human circadian metabolome","volume":"109","author":"Dallmann","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180305091448_CIT0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0447.2012.01917.x","article-title":"Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatment","volume":"127","author":"Drancourt","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"key\n\t\t\t\t20180305091448_CIT0014","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"key\n\t\t\t\t20180305091448_CIT0015","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4088\/JCP.v67n1217","article-title":"Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry","volume":"67","author":"Freeman","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0016","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pcn.12322","article-title":"Schizophrenia in 2020: trends in diagnosis and therapy","volume":"69","author":"Gaebel","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20180305091448_CIT0017","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.3214","article-title":"Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs","volume":"19","author":"Gulbins","year":"2013","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180305091448_CIT0018","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/jnc.13145","article-title":"A central role for the acid sphingomyelinase\/ceramide system in neurogenesis and major depression","volume":"134","author":"Gulbins","year":"2015","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20180305091448_CIT0019","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archpsyc.1985.01790320076010","article-title":"Cortisol secretion in endogenous depression. I. Basal plasma levels","volume":"42","author":"Halbreich","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0021","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.biopsych.2013.09.035","article-title":"Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research","volume":"75","author":"Hayashi-Takagi","year":"2014","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0022","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.mp.4000696","article-title":"Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder","volume":"5","author":"Johnston-Wilson","year":"2000","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0023","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/NEN.0000000000000091","article-title":"Metabolomics of human brain aging and age-related neurodegenerative diseases","volume":"73","author":"Jov\u00e9","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20180305091448_CIT0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180305091448_CIT0025","article-title":"Relationship between erythrocyte fatty acid composition and psychopathology in the Vienna omega-3 study","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180305091448_CIT0026","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/pcn.12299","article-title":"Biochemical markers subtyping major depressive disorder","volume":"69","author":"Kunugi","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20180305091448_CIT0027","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/14622416.9.4.383","article-title":"Analysis of the adult human plasma metabolome","volume":"9","author":"Lawton","year":"2008","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20180305091448_CIT0028","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2007.06.094","article-title":"Prefrontal white matter abnormalities in young adult with major depressive disorder: a diffusion tensor imaging study","volume":"1168","author":"Li","year":"2007","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20180305091448_CIT0029","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2010.03.018","article-title":"A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression","volume":"68","author":"Lin","year":"2010","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0030","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1046\/j.1471-4159.1998.71062528.x","article-title":"Fatty acid composition of human brain phospholipids during normal development","volume":"71","author":"Mart\u00ednez","year":"2002","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20180305091448_CIT0031","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20180305091448_CIT0032","first-page":"334","article-title":"Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids","volume":"51","author":"Moser","year":"1981","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180305091448_CIT0033","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.2004.055129","article-title":"Frontal white matter anisotropy and symptom severity of late-life depression: a magnetic resonance diffusion tensor imaging study","volume":"77","author":"Nobuhara","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0034","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/15622970410029917","article-title":"Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients","volume":"5","author":"Peet","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0035","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4088\/JCP.08m04994yel","article-title":"Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood","volume":"71","author":"Post","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0036","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbalip.2011.07.006","article-title":"High sensitivity quantitative lipidomics analysis of fatty acids in biological samples by gas chromatography-mass spectrometry","volume":"1811","author":"Quehenberger","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180305091448_CIT0037","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","article-title":"Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline","volume":"30","author":"Reddy","year":"2004","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180305091448_CIT0038","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0039","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/460202a","article-title":"Biomarkers in psychiatry","volume":"460","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180305091448_CIT0040","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ajp.2013.12111448","article-title":"Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives","volume":"170","author":"Skudlarski","year":"2013","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0041","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1399-5618.2007.00387.x","article-title":"Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania","volume":"9","author":"Sublette","year":"2007","journal-title":"Bipolar Disord"},{"key":"key\n\t\t\t\t20180305091448_CIT0042","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-5618.2008.00646.x","article-title":"White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging","volume":"11","author":"Sussmann","year":"2009","journal-title":"Bipolar Disord"},{"key":"key\n\t\t\t\t20180305091448_CIT0043","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/joe.0.0760165","article-title":"Levels of cortisol, corticosterone, cortisone and 11-deoxycoritsol in the plasma of stressed and unstressed subjects","volume":"76","author":"Tacker","year":"1978","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t20180305091448_CIT0044","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.clinpsy.4.022007.141248","article-title":"Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia","volume":"4","author":"Walker","year":"2008","journal-title":"Annu Rev Clin Psychol"},{"key":"key\n\t\t\t\t20180305091448_CIT0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1210\/jcem.85.3.6469","article-title":"Increased diurnal plasma concentrations of cortisone in depressed patients","volume":"85","author":"Weber","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180305091448_CIT0046","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1038\/tp.2011.56","article-title":"Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation","volume":"1","author":"Webhofer","year":"2011","journal-title":"Transl Psychiatry"},{"key":"key\n\t\t\t\t20180305091448_CIT0047","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5650\/jos.ess13226","article-title":"Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome","volume":"63","author":"Yamazaki","year":"2014","journal-title":"J Oleo Sci"},{"key":"key\n\t\t\t\t20180305091448_CIT0048","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1017\/S0007114517001003","article-title":"Blood fatty acid changes in healthy young Americans in response to a 10-week diet that increased n-3 and reduced n-6 fatty acid consumption: a randomised controlled trial","volume":"117","author":"Young","year":"2017","journal-title":"Br J Nutr"},{"key":"key\n\t\t\t\t20180305091448_CIT0049","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/21\/3\/207\/24250357\/pyx089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T09:15:08Z","timestamp":1520241308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/21\/3\/207\/4356809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,10,6]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyx089","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,10,6]]}}}